Barts Health NHS Trust is an NHS trust based in London, England. Established in 2012, it runs five hospitals throughout the City of London and East London, and is one of the largest NHS trusts in England.

During the past decade, Barts Health NHS Trust conducted 186 clinical trials. In the 10-year time frame, 186 clinical trials started and 59 clinical trials were completed, i.e. on average, 31.7% percent of trials that started reached the finish line to date. In the past 5 years, 68 clinical trials started and 34 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Barts Health NHS Trust" #1 sponsor was "Queen Mary University of London" with 36 trials, followed by "Barts & The London NHS Trust" with 29 trials sponsored, "Gilead Sciences" with 27 trials sponsored, "Hoffmann-La Roche" with 10 trials sponsored and "University College, London" with 10 trials sponsored. Other sponsors include 143 different institutions and companies that sponsored additional 103 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Barts Health NHS Trust" #1 collaborator was "Barts & The London NHS Trust" with 15 trials as a collaborator, "Cancer Research UK" with 9 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 8 trials as a collaborator, "King's College London" with 7 trials as a collaborator and "Merck Sharp & Dohme LLC" with 6 trials as a collaborator. Other collaborators include 217 different institutions and companies that were collaborators in the rest 158 trials.

According to Clinical.Site data, the most researched conditions in "Barts Health NHS Trust" are "Atrial Fibrillation" (6 trials), "Crohn's Disease" (6 trials), "HIV Infections" (6 trials), "Breast Cancer" (5 trials) and "HIV-1 Infection" (5 trials). Many other conditions were trialed in "Barts Health NHS Trust" in a lesser frequency.

Most popular intervention types in "Barts Health NHS Trust" are "Drug" (140 trials), "Other" (39 trials), "Device" (25 trials), "Procedure" (22 trials) and "Biological" (19 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Atezolizumab" (7 trials), "Gemcitabine" (5 trials), "Paclitaxel" (5 trials) and "ATV" (4 trials). Other intervention names were less common.

The vast majority of trials in "Barts Health NHS Trust" are 233 trials for "All" genders, 24 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Barts Health NHS Trust". 3 are not yet recruiting, 45 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 122 completed trials in Barts Health NHS Trust, 2 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Barts Health NHS Trust, 11 "Phase 1" clinical trials were conducted, 70 "Phase 2" clinical trials and 83 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 50 trials that are defined as “Not Applicable".

Barts Health NHS Trust has several departments that took part in Clinical trials: "Barts Heart Centre" - 22 trials, "Barts and The London Dental Hospital" - 8 trials, "Royal London Children's Hospital" - 2 trials, "St. Bartholomew's Hosp., Infection & Immunity Clinical Group CRS" - 2 trials